Protocadherin-PC discovery and its implication in prostate cancer progression
Vacherot, F.; Terry, Séphane.; Faucon, H.; Queires, L.; Chen, M-Wei.; Yang, X.; Gil Diez de Medina, S.; Verdier, A.; Azoulay, S.; Allory, Y.; Abbou, C.C.; Buttyan, R.; de la Taille, A.
Progres en Urologie Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 15(6 Suppl. 1): 1294-1302
2005
ISSN/ISBN: 1166-7087 PMID: 16734220 Document Number: 593393
Document emailed within 1 workday
Related Documents
Giannakopoulos, X.; Stagikas, D.; Peschos, D.; Batistatou, A.; Charalabopoulos, K. 2007: Implication of protocadherin-PC in the progression of the advanced prostate cancer Experimental Oncology 29(1): 74-75Murray, N.P.; Aedo, S.óc.; Fuentealba, C.; Reyes, E.; Minzer, S.; Salazar, A.íb. 2019: Circulating prostate cells and bone marrow micrometastasis are determinant in risk and time to biochemical progression in localized prostate cancer Archivos Espanoles de Urologia 72(5): 471-482
Harada, M. 2002: Histological classification of prostate cancer with clinicopathological implication Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 76-81
Chen, H.-J.; Wang, H.; Zhang, L.; Zhang, Y.-K.; Wang, G.-M. 2006: Correlation between integrin subunits alpha5 and beta1 expressions in prostate cancer and its clinical implication Zhonghua Nan Ke Xue 12(2): 148-150
Mocarska, A.; Czarnocki, K.; Starosławska, E.; Janczarek, M.; Zelazowska-Cieslińska, I.; Losicki, M.; Burdan, F. 2014: Evaluation of prostate cancer progression Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 37(222): 356-364
Newling, D.W. 1990: Parameters of response and progression in prostate cancer Progress in Clinical and Biological Research 359: 25-48; Discussion: 73-74
Kanoh, Y.; Mashiko, T.; Danbara, M.; Takayama, Y.; Ohtani, S.; Egawa, S.; Baba, S.; Akahoshi, T. 2004: Changes in serum IgG oligosaccharide chains with prostate cancer progression Anticancer Research 24(5b): 3135-3139
Teishima, J.; Matsubara, A. 2016: Mechanism of development and progression in prostate cancer: Overview Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 80-86
Feng, W.; Zhang, H.-b.; Wang, Y.-m.; Hu, J.-l. 2015: Correlation of FOXA1 with the malignancy and progression of prostate cancer Zhonghua Nan Ke Xue 21(5): 414-419
Jenster, G. 1999: The role of the androgen receptor in the development and progression of prostate cancer Seminars in Oncology 26(4): 407-421
Shimazaki, J. 1998: Development and progression of prostate cancer in relation with androgen dependency Nihon Rinsho. Japanese Journal of Clinical Medicine 56(8): 1953-1958
Parsons, J.K.; Marshall, J.R.; Nelson, H. 2013: Does altering diet affect progression of prostate cancer? the MEAL study Bulletin of the American College of Surgeons 98(10): 57-59
Lokeshwar, V.B.; Lokeshwar, B.L.; Pham, H.T.; Block, N.L. 1996: Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression Cancer Research 56(3): 651-657
Spanjol, J.; Maricić, A.; Valencić, M.; Oguić, R.; Krpina, K.; Protić, A.; Ivancić, A.; Bobinac, M.; Fuckar, D.; Vojniković, B. 2008: Influence of insolation on osteoporosis progression in androgen deprived nonmetastatic prostate cancer patients Collegium Antropologicum 32(Suppl 2): 79-81
Yamada, Y.; Fujiwara, H.; Somiya, S.; Fujikawa, S.; Kamiyama, Y.; Tamaki, M.; Kanaoka, T. 2018: Delay in High-Grade Metastatic Prostate Cancer Progression by Dutasteride : A Case Report Hinyokika Kiyo. Acta Urologica Japonica 64(4): 187-192
Almeras, C.; Zerbib, M.; Eschwege, F.ço.; Debré, B. 2002: Nadir PSA and kinetics of PSA decline between the 3rd and 6th month after external beam radiotherapy for T1 T2 Nx M0 localized prostate cancer: value of the prediction of the risk of biological progression Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 12(2): 219-225
Lee, J.; Wang, A.; Hu, Q.; Lu, S.; Dong, Z. 2006: Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice International Journal of Oncology 29(6): 1405-1412
Callea, A.; Piccinni, R.; Zizzi, V.; Sblendorio, D.; Berardi, B.; Tempesta, A.; Gala, F.G.; Traficante, A. 2010: High-intensity focused ultrasound (HIFU) in prostate cancer: a single centre experience in patients with low, intermediate or high-risk of progression Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 82(4): 253-255
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24